N
11.95
0.49 (4.28%)
| Penutupan Terdahulu | 11.46 |
| Buka | 11.43 |
| Jumlah Dagangan | 1,991,250 |
| Purata Dagangan (3B) | 1,617,795 |
| Modal Pasaran | 1,338,184,704 |
| Harga / Jualan (P/S) | 2.05 |
| Harga / Buku (P/B) | 4.03 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Oct 2025 |
| Margin Keuntungan | -26.41% |
| Margin Operasi (TTM) | -24.43% |
| EPS Cair (TTM) | -1.51 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 11.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 192.49% |
| Nisbah Semasa (MRQ) | 1.47 |
| Aliran Tunai Operasi (OCF TTM) | -30.46 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 16.94 M |
| Pulangan Atas Aset (ROA TTM) | -8.64% |
| Pulangan Atas Ekuiti (ROE TTM) | -45.52% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | NovoCure Limited | Menaik | Menurun |
AISkor Stockmoo
1.9
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | 2.0 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 5.0 |
| Osilator Teknikal | -0.5 |
| Purata | 1.90 |
|
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 9.84% |
| % Dimiliki oleh Institusi | 87.40% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 49.00 (HC Wainwright & Co., 310.04%) | Beli |
| Median | 33.50 (180.34%) | |
| Rendah | 18.00 (Wedbush, 50.63%) | Pegang |
| Purata | 33.50 (180.34%) | |
| Jumlah | 1 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 13.78 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 26 Feb 2026 | 49.00 (310.04%) | Beli | 13.75 |
| 12 Feb 2026 | 47.00 (293.31%) | Beli | 12.53 | |
| Wedbush | 15 Jan 2026 | 18.00 (50.63%) | Pegang | 13.80 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BEN ARYE BARAK | 13.30 | - | 50,125 | 666,663 |
| BRACKMANN CHRISTOPH | 13.30 | 13.42 | 48,725 | 647,273 |
| CORDOVA ASHLEY | - | 13.42 | -17,638 | -236,702 |
| DOYLE WILLIAM F | 13.30 | 13.30 | 328,397 | 4,367,680 |
| LEONARD FRANK X | 13.30 | 13.42 | 144,393 | 1,919,754 |
| LEUPIN NICOLAS | - | 13.42 | -1,100 | -14,762 |
| PARAVASTHU MUKUND | 13.30 | 13.83 | -3,511 | -87,560 |
| PURI MICHAL NATH | 13.30 | 13.42 | 39,000 | 518,568 |
| WEINBERG URI | 13.30 | 13.42 | 43,713 | 580,613 |
| Jumlah Keseluruhan Kuantiti Bersih | 632,104 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 8,361,527 | |||
| Purata Pembelian Keseluruhan ($) | 13.30 | |||
| Purata Jualan Keseluruhan ($) | 13.50 | |||
| Julat Insider ($) | ||||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| PARAVASTHU MUKUND | Pegawai | 05 Mar 2026 | Jual (-) | 43,246 | 14.23 | 615,391 |
| PURI MICHAL NATH | Pegawai | 04 Mar 2026 | Jual (-) | 1,100 | 13.42 | 14,762 |
| PARAVASTHU MUKUND | Pegawai | 04 Mar 2026 | Jual (-) | 5,377 | 13.42 | 72,159 |
| LEONARD FRANK X | Pegawai | 04 Mar 2026 | Jual (-) | 5,607 | 13.42 | 75,246 |
| BRACKMANN CHRISTOPH | Pegawai | 04 Mar 2026 | Jual (-) | 6,412 | 13.42 | 86,049 |
| WEINBERG URI | Pegawai | 04 Mar 2026 | Jual (-) | 6,412 | 13.42 | 86,049 |
| CORDOVA ASHLEY | Pegawai | 04 Mar 2026 | Dibuang (-) | 17,638 | 13.42 | 236,702 |
| LEUPIN NICOLAS | Pegawai | 04 Mar 2026 | Jual (-) | 1,100 | 13.42 | 14,762 |
| DOYLE WILLIAM F | Pegawai | 03 Mar 2026 | Diperolehi (+) | 400,284 | 13.30 | 5,323,777 |
| DOYLE WILLIAM F | Pegawai | 03 Mar 2026 | Jual (-) | 71,887 | 13.30 | 956,097 |
| PURI MICHAL NATH | Pegawai | 03 Mar 2026 | Diperolehi (+) | 40,100 | 13.30 | 533,330 |
| PARAVASTHU MUKUND | Pegawai | 03 Mar 2026 | Diperolehi (+) | 45,112 | 13.30 | 599,990 |
| LEONARD FRANK X | Pegawai | 03 Mar 2026 | Diperolehi (+) | 150,000 | 13.30 | 1,995,000 |
| BRACKMANN CHRISTOPH | Pegawai | 03 Mar 2026 | Diperolehi (+) | 55,137 | 13.30 | 733,322 |
| WEINBERG URI | Pegawai | 03 Mar 2026 | Diperolehi (+) | 50,125 | 13.30 | 666,663 |
| BEN ARYE BARAK | Pegawai | 03 Mar 2026 | Diperolehi (+) | 50,125 | 13.30 | 666,663 |
| Papar semua | ||||||
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Jan 2026 | Pengumuman | Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update |
| 22 Dec 2025 | Pengumuman | Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |